ScienceCloses Jul 23 · Results Jul 24

Will the FDA approve BPC-157 for compounding on July 23–24, 2026?

52%

Stable · last 24h

📊 0 bettors💎 0 at stake

Your stake

💎10

Potential payout

—

🤖 Context

This market will resolve to YES if the FDA's Pharmacy Compounding Advisory Committee votes to add BPC-157 to the Section 503A bulk drug substances list during their meeting on July 23–24, 2026. It will resolve to NO if the committee votes against its inclusion.

🔍 Sources

Sources used to create this market

🔗
peptidemark.compeptidemark.com
🔗
fda.govfda.gov
🔗
fda.govfda.gov